PERSISTA BIO INC
Delivering the promise of biotherapeutics
ITHACA, United States · Founded 2025
- Headquarters
- ITHACA, New York
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- persistabio.com
About
Persista Bio is a seed-stage biotherapeutics company developing the O2Line system, a long-term cell implant designed to automatically regulate blood sugar for Type 1 diabetes patients. The technology, licensed from Cornell University and Giner, Inc., aims to replace daily insulin management by mimicking the body's natural processes without requiring immunosuppression.
Summary
PERSISTA BIO INC is a Biotech company based in ITHACA, United States, founded in 2025.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/persista-bio-inc"><img src="https://indexed.vc/api/badge/company/persista-bio-inc" alt="PERSISTA BIO INC on Indexed.vc" width="260" height="76" /></a>